Scott Lovell
Indiana University Health(US)Center for Infectious Disease Research(US)University of Kansas(US)Indiana Cancer Consortium(US)Indiana University – Purdue University Indianapolis(US)
Publications by Year
Research Areas
RNA modifications and cancer, Enzyme Structure and Function, Bacterial Genetics and Biotechnology, Cancer-related Molecular Pathways, Cancer Genomics and Diagnostics
Most-Cited Works
- → R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation(2006)509 cited
- → Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses(2012)374 cited
- → 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice(2020)295 cited
- → Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124(2010)175 cited
- → The Min Oscillator Uses MinD-Dependent Conformational Changes in MinE to Spatially Regulate Cytokinesis(2011)169 cited
- → The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase(2020)138 cited